{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:32:43Z","timestamp":1793871163859,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jocn-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jocn.2025.111099","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T21:39:59Z","timestamp":1738618799000},"page":"111099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A new paradigm for neurodegenerative diseases classification: A clinical perspective"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-9979","authenticated-orcid":false,"given":"Alexandros","family":"Giannakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiridon","family":"Konitsiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2025.111099_b0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"10.1016\/j.jocn.2025.111099_b0010","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2025.111099_b0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2025.111099_b0020","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2025.111099_b0025","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2025.111099_b0030","first-page":"648","article-title":"Alzheimer Disease. CONTINUUM: Lifelong Learning","volume":"28","author":"McDade","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2025.111099_b0035","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00259-018-4030-3","article-title":"Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders","volume":"45","author":"Nobili","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jocn.2025.111099_b0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2025.111099_b0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mdc3.12807","article-title":"Utility of the Movement Disorders Society Criteria for Progressive Supranuclear Palsy in Clinical Practice","volume":"6","author":"Ali","year":"2019","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.jocn.2025.111099_b0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.parkreldis.2019.10.012","article-title":"Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?","volume":"69","author":"Shoeibi","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jocn.2025.111099_b0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pjnns.2015.10.002","article-title":"The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice","volume":"49","author":"D\u0105browska","year":"2015","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.jocn.2025.111099_b0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mds.27872","article-title":"Validation of the Movement Disorder Society Criteria for the Diagnosis of 4\u2010Repeat Tauopathies","volume":"35","author":"Respondek","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2025.111099_b0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2025.111099_b0070","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/mds.27666","article-title":"How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy","volume":"34","author":"Grimm","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2025.111099_b0075","first-page":"464","article-title":"Frontotemporal Dementias. CONTINUUM: Lifelong Learning","volume":"22","author":"Finger","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2025.111099_b0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jocn.2025.111099_b0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jocn.2025.111099_b0090","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jnen\/nlz080","article-title":"Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging","volume":"78","author":"Adler","year":"2019","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jocn.2025.111099_b0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mds.26874","article-title":"Profile of cognitive impairment and underlying pathology in multiple system atrophy","volume":"32","author":"Koga","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2025.111099_b0100","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2025.111099_b0105","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2025.111099_b0110","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2025.111099_b0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","article-title":"Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders","volume":"85","author":"Coughlin","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2025.111099_b0120","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/brain\/awy153","article-title":"A broader view of dementia: multiple co-pathologies are the norm","volume":"141","author":"Coulthard","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2025.111099_b0125","first-page":"128","volume":"25","author":"Lewy","year":"2019","journal-title":"CONTINUUM: Lifelong Learning, Neurology"},{"key":"10.1016\/j.jocn.2025.111099_b0130","doi-asserted-by":"crossref","DOI":"10.1007\/s00234-024-03432-w","article-title":"Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study","author":"Sakurai","year":"2024","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jocn.2025.111099_b0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13195-017-0287-1","article-title":"Can cognitive assessment really discriminate early stages of Alzheimer\u2019s and behavioural variant frontotemporal dementia at initial clinical presentation?","volume":"9","author":"Reul","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jocn.2025.111099_b0140","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.3390\/ijms23126371","article-title":"Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer\u2019s Disease","volume":"23","author":"Bousiges","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jocn.2025.111099_b0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2019.05.014","article-title":"Regional neuropathology distribution and verbal fluency impairments in Parkinson\u2019s disease","volume":"65","author":"El-Nazer","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jocn.2025.111099_b0150","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.jocn.2025.111099_b0155","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1474-4422(23)00447-7","article-title":"European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders","volume":"23","author":"Frisoni","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2025.111099_b0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-023-00637-0","article-title":"Anti-amyloid therapies for Alzheimer disease: finally, good news for patients","volume":"18","author":"Ramanan","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jocn.2025.111099_b0165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"10.1016\/j.jocn.2025.111099_b0170","doi-asserted-by":"crossref","DOI":"10.1142\/S0218213018500112","article-title":"Machine Learning for Neurodegenerative Disorder Diagnosis \u2014 Survey of Practices and Launch of Benchmark Dataset","volume":"27","author":"Tagaris","year":"2018","journal-title":"Int J Artif Intell Tools"},{"key":"10.1016\/j.jocn.2025.111099_b0175","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/molecules29030722","article-title":"Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers","volume":"29","author":"Bisi","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jocn.2025.111099_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2021.104400","article-title":"Physical performance across the cognitive spectrum and between dementia subtypes in a population-based sample of older adults: The HUNT study","volume":"95","author":"Sverdrup","year":"2021","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jocn.2025.111099_b0185","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13195-024-01607-4","article-title":"Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer\u2019s disease progression: a systematic review","volume":"16","author":"Costanzo","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jocn.2025.111099_b0190","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/pn-2023-003988","article-title":"Pathology of neurodegenerative disease for the general neurologist","volume":"24","author":"Cullinane","year":"2024","journal-title":"Pract Neurol"},{"key":"10.1016\/j.jocn.2025.111099_b0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-024-00407-y","article-title":"Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration","volume":"13","author":"Li","year":"2024","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.jocn.2025.111099_b0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jocn.2020.04.088","article-title":"Clinicopathological overlap of neurodegenerative diseases: A comprehensive review","volume":"78","author":"Das","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2025.111099_b0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13024-024-00782-0","article-title":"Dementia with lewy bodies patients with high tau levels display unique proteome profiles","volume":"19","author":"Greally","year":"2024","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jocn.2025.111099_b0210","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s41591-024-02843-9","article-title":"Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing","volume":"30","author":"Mekkes","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jocn.2025.111099_b0215","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41582-020-0377-8","article-title":"Applications of machine learning to diagnosis and treatment of neurodegenerative diseases","volume":"16","author":"Myszczynska","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2025.111099_b0220","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41598-024-83975-3","article-title":"Machine learning for early detection and severity classification in people with Parkinson\u2019s disease","volume":"15","author":"Hwang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2025.111099_b0225","doi-asserted-by":"crossref","first-page":"31234","DOI":"10.1038\/s41598-024-82528-y","article-title":"Concordance and test-retest consistency of sleep biomarker-based neurodegenerative disorder profiling","volume":"14","author":"Levendowski","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2025.111099_b0230","first-page":"631","article-title":"Uncovering Important Diagnostic Features for Alzheimer\u2019s, Parkinson\u2019s and Other Dementias Using Interpretable Association Mining Methods","volume":"30","author":"Noshin","year":"2025","journal-title":"Pac Symp Biocomput"},{"key":"10.1016\/j.jocn.2025.111099_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155671","article-title":"The emerging role of artificial intelligence in neuropathology: Where are we and where do we want to go?","volume":"263","author":"Broggi","year":"2024","journal-title":"Pathol Res Pract"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825000712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825000712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:36:23Z","timestamp":1744353383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":47,"alternative-id":["S0967586825000712"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111099","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new paradigm for neurodegenerative diseases classification: A clinical perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111099"}}